Charles B. Haaser was named Vice President of Finance and Chief Accounting Officer in October 2016 in conjunction with the transition to Yield10 Bioscience as the company's core business. Mr. Haaser joined Metabolix in 2008 as Corporate Controller and was named Chief Accounting Officer in November 2014. Mr. Haaser has more than 30 years of experience in accounting and finance, primarily working for publicly traded U.S. companies. Before joining Metabolix, Mr. Haaser was the Corporate Controller of Indevus Pharmaceuticals, Inc. from 2006 to 2008. He was the Corporate Controller and Principal Accounting Officer at ABIOMED, Inc. from 1998 to 2006 and additionally served as ABIOMED's Acting Chief Financial Officer from 2003 to 2006. From 1997 to 1998, Mr. Haaser was the controller for Technical Communications Corporation, and from 1986 to 1997, he was the Director of Finance at ISI Systems, Inc. Prior to that, Mr. Haaser was an auditor in the commercial audit division of Price Waterhouse LLP (now PricewaterhouseCoopers LLP). Mr. Haaser received a bachelor's degree in business administration (finance) from the University of Notre Dame, an M.B.A. from Northeastern University, and an M.S. in taxation from Bentley University. Mr. Haaser became a Certified Public Accountant in 1997.
